Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics, Inc. (LXEO) has reported earnings 10 times since Dec 11, 2023. The stock moves an average of ±9.71% the day after reporting, closing higher 60.0% of the time. Its largest post-earnings gain was +50.92% (Mar 24, 2025) and its largest decline was -12.94% (Dec 11, 2023). The next earnings report is predicted for 2026-08-13 (high confidence).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±9.71%
Positive %
60.0%
Negative %
40.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | ☽ POST | $5.47 | $5.51 | $5.27 | 828,100 | +8.92% | open_in_new |
| Nov 05, 2025 | ☀ PRE | $8.27 | $8.52 | $8.20 | 2,249,300 | -1.8% | open_in_new |
| Aug 14, 2025 | ☀ PRE | $4.71 | $4.99 | $4.79 | 377,300 | +1.48% | open_in_new |
| May 12, 2025 | ☀ PRE | $2.79 | $3.11 | $2.63 | 1,018,900 | -2.23% | open_in_new |
| Mar 24, 2025 | ☀ PRE | $2.99 | $4.27 | $4.09 | 6,952,100 | +50.92% | open_in_new |
| Nov 13, 2024 | ☀ PRE | $8.65 | $11.72 | $7.64 | 5,967,600 | -0.65% | open_in_new |
| Aug 12, 2024 | ☀ PRE | $11.47 | $12.01 | $11.98 | 118,300 | +4.17% | open_in_new |
| May 09, 2024 | ☀ PRE | $13.44 | $16.79 | $14.50 | 245,700 | +5.69% | open_in_new |
| Mar 11, 2024 | ☽ POST | $16.17 | $16.17 | $14.49 | 289,500 | +8.28% | open_in_new |
| Dec 11, 2023 | ☀ PRE | $11.00 | $11.00 | $10.09 | 73,100 | -12.94% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±9.71%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 4 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
| 144 | 20260518 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260515 | open_in_new SEC.gov |
| 3 | 20260430 | open_in_new SEC.gov |
| 4 | 20260430 | open_in_new SEC.gov |
| 8-K | 20260430 | open_in_new SEC.gov |
Frequently asked about LXEO earnings
When does Lexeo Therapeutics, Inc. report earnings next? expand_more
Lexeo Therapeutics, Inc. (LXEO)'s next earnings date is predicted (high confidence) for 2026-08-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does LXEO stock move after earnings? expand_more
Over 10 reports, LXEO has moved an average of ±9.71% the session after earnings, closing higher 60.0% of the time.
What was LXEO's biggest post-earnings move? expand_more
LXEO's largest post-earnings gain on record was +50.92% on Mar 24, 2025, and its largest decline was -12.94% on Dec 11, 2023.
Where can I find Lexeo Therapeutics, Inc.'s SEC filings? expand_more
All of Lexeo Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right